Geneva, May 4 -- International Clinical Trials Registry received information related to the study (CTRI/2026/04/108972) titled 'Efficacy and safety of Anti-pigmentation Activity of Pureplay BL Gel Serum' on April 21.
Study Type: PMS
Study Design:
Single Arm Study Method of generating randomization sequence:Not Applicable Method of allocation concealment:Not Applicable Blinding and masking:Open Label
Primary Sponsor: Pureplay Skin Sciences Pvt Ltd
Intervention:
Intervention1: Test Product: BL Gel Serum: Test Product: BL Gel Serum
Dose: 5-6 drops applied on face and neck area twice a day (morning + night)
Route of Administration: Topical
Control Intervention1: Not Applicable: Not Applicable
Recruitment Status: Not Recruiting
P...